Syngene International539268Pharmaceuticals, CDMO
Syngene, from the CDMO space, delivered a very strong set of numbers
By ScoutQuest · · 1 min read
Heard on business television between 15:36:56 - 15:39:56 IST.
- Syngene was cited along with Piramal Pharma as a CDMO space stock with very strong set of numbers.
- Delivered robust results that were well received by the street.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Syngene International
Syngene International uploads audio recording of Q2 FY27 post-earnings call held October 28, 2026
28 Oct 2026
Syngene International reported 13% sequential growth in Q2 FY27 driven by CDMO business, with stock up 6%, while maintaining full-year guidance of single-digit revenue decline
28 Oct 2026
Syngene reported a strong sequential turnaround in Q2 with margin improvement and return to profit
28 Oct 2026
Source: Live TV News Channel · 28 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.